chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pain in extremity, Rash erythematous, Swelling
Clinical narrative: Immediately following the vaccine my arm was sore, hot and swelling started to occur. Throughout the day it got worse. The next day it was extremely painful, and hard for me to lift my arm. A rash was forming on the site of injection and injection point is yellow in color also extreme swelling. As of today May 26, 2021 I have a red rash patch approx. 4inches x3 inch on my right arm and a yellow dot where needle was injected. I feel fine, I can lift arm w/out pain,  swelling has gone down completely. Rash remains.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nausea, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Dx Covid-19 Screening  ? Generalized Body Aches ? Fever  ? Nausea
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac normal, Echocardiogram normal, Magnetic resonance imaging heart, Myocarditis, Troponin I increased
Clinical narrative: Patient presented with a myopericarditis with elevated troponin, normal LV function, normal coronary arteries.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient came  for second Pfizer vaccine.  Vaccine was administered, then it was noted that first vaccine was given 5-7-21, and second dose was not due to be given before 5-28-21.  No immediate side effects noted with after care.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received Moderna for first vaccine but was given Pfizer for second dose
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache and fever of 99.1 F. Tylenol 500 mg two tablets taken twice in a 12 hour period. Luke warm showers taken, as well cool towel compress. Fever reduced
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Herpes simplex, Pain, Pyrexia
Clinical narrative: Herpes simplex outbreak buttocks Increased  coughing, enough to keep me up at night Fever 100.5 for 24 hours Headache/body aches
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Swelling, Swelling face
Clinical narrative: Moderna COVID-19 Vaccine EUA- Hard lump the size of a marble on the right collarbone, swelling of the face and neck above area.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, IPV, PNC13, RV5
Symptoms: Extra dose administered, Pyrexia
Clinical narrative: Patient was given 2 doses of polio accidently. Patient had a fever the next day, which subsided same day.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Migraine, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Tinnitus (ears ringing)--ongoing to date. Ears popping and fullness--ongoing to date. Arm soreness--4 days, nausea--1 day. Fever 101 degrees lasted for the day. Migraine--3 days.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus (ears ringing)--ongoing to date. Ears popping and fullness--ongoing to date. Arm soreness--4 days, nausea--1 day. Fever 101 degrees lasted for the day. Migraine--3 days.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Bacterial infection, Bilevel positive airway pressure, Blood culture positive
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Catheter placement, Condition aggravated, Cough
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Diarrhoea, Disseminated intravascular coagulation, Dyspnoea, Endotracheal intubation
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Fluid replacement, General physical health deterioration, Gram stain positive, Haemodynamic instability
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Heparin-induced thrombocytopenia test, Hypoxia, Intensive care, Lung assist device therapy, Mechanical ventilation
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Packed red blood cell transfusion, Peripheral artery thrombosis, Peripheral coldness, Platelet transfusion, Prone position
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pulseless electrical activity, SARS-CoV-2 test positive, Septic shock, Transfusion, Ultrasound Doppler abnormal
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vasopressive therapy, Vena cava thrombosis
Clinical narrative: Presented 5/13 to Hospital.  Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8.   Treatments prior to arrival included remdesivir and dexamethasone, started 5/13.  She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018.  Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17.   Paralysis and proning initiated.  Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning.   CTS asked to place patient on VV ECMO.    5/20/21 1135am  initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week.  Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids.  Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab.  Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17.  Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent.  On 5/19 patient continued to decline despite paralytic and pronning.  Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation
Clinical narrative: Constipation/ laxatives hardly work
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Hyperhidrosis, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Headache, Sore Throat, Body Aches, Fever
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Oropharyngeal pain, Periorbital swelling
Clinical narrative: Patient had puffy eyes, a sore throat, and said her throat felt "thick"
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Vomiting
Clinical narrative: AE: patient got dizzy, vomited and syncopal walking. No medication was given. food and water improved the symptoms Outcome: patient discharged to POV/Home
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Human metapneumovirus test, Influenza A virus test negative, Influenza B virus test, Respiratory viral panel
Clinical narrative: shortness of breath
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: shortness of breath
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Since my vaccine, I've had swollen glands in my neck and under my ear.  It is not getting better.  I went to my primary care doctor and got a prednisone pack (4 days), but it did not decrease the swelling.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Hyperhidrosis, Injection site swelling, Nausea, Pyrexia
Clinical narrative: Patient received initial Moderna vaccine on 4/21/2021 and had injection site reaction of Left upper arm (erythema and induration about size of soft ball) start 4 to 5 days later and resolved 4-5 days later. She then got the second Moderna vaccine Sat 5/22/2021 in the same arm and the following morning developed nausea, vomiting, diarrhea, fever, and diaphoresis.  Her left arm developed injection site reaction starting small and then size of 2 baseballs put together.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient received initial Moderna vaccine on 4/21/2021 and had injection site reaction of Left upper arm (erythema and induration about size of soft ball) start 4 to 5 days later and resolved 4-5 days later. She then got the second Moderna vaccine Sat 5/22/2021 in the same arm and the following morning developed nausea, vomiting, diarrhea, fever, and diaphoresis.  Her left arm developed injection site reaction starting small and then size of 2 baseballs put together.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood albumin decreased, Blood calcium increased, Blood chloride decreased, Blood sodium decreased, Blood urea increased
Clinical narrative: Pt received vaccine on 4/8/2021. Pt was diagnosed with COVID-19 on 5/17/2021. Pt was admitted to the hospital on 5/21/2021 for pneumonia secondary to COVID-19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax
Clinical narrative: Pt received vaccine on 4/8/2021. Pt was diagnosed with COVID-19 on 5/17/2021. Pt was admitted to the hospital on 5/21/2021 for pneumonia secondary to COVID-19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Full blood count abnormal, Haematocrit decreased, Haemoglobin increased, Hilar lymphadenopathy
Clinical narrative: Pt received vaccine on 4/8/2021. Pt was diagnosed with COVID-19 on 5/17/2021. Pt was admitted to the hospital on 5/21/2021 for pneumonia secondary to COVID-19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Immature granulocyte count, Lung infiltration, Lung opacity, Lymphocyte count increased, Mean cell haemoglobin decreased
Clinical narrative: Pt received vaccine on 4/8/2021. Pt was diagnosed with COVID-19 on 5/17/2021. Pt was admitted to the hospital on 5/21/2021 for pneumonia secondary to COVID-19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume decreased, Metabolic function test, Protein total decreased, White blood cell count increased
Clinical narrative: Pt received vaccine on 4/8/2021. Pt was diagnosed with COVID-19 on 5/17/2021. Pt was admitted to the hospital on 5/21/2021 for pneumonia secondary to COVID-19.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dermal filler injection, Lip swelling
Clinical narrative: The nurse asked me if I had dermafillers and I told her that I do. She asked when I got them, I told her that it has been 2 years, so she said that it?s too old to show effects and did the vaccine. 1-1,5 days later my lips got swollen as if they were going to explode. it was like that for 3 days until it started going back down. It was scary.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Unevaluable event
Clinical narrative: UNKNOWN
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Patient fully vaccinated with Pfizer vaccine on 1/28/2021 and 2/24/2021.  Patient diagnosed with Covid19 on May 25, 2021 with a rapid PCR test after a known exposure to a Covid positive person
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Chills, Fatigue, Pain, Pain in extremity
Clinical narrative: I had a fever, aches, chills, fatigue for approximately 24 hours. In addition, I had sharp pain (only when walking) in my right lower abdomen and in the second toe on my left foot.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I had a fever, aches, chills, fatigue for approximately 24 hours. In addition, I had sharp pain (only when walking) in my right lower abdomen and in the second toe on my left foot.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rectal haemorrhage
Clinical narrative: Bleeding from rectum, as though having a period, for about 5 to 10 minutes with spotting before and after then nothing
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Nipple exudate bloody
Clinical narrative: Blood spotting around left nipple (seen in two bralets and tank top- she did not feel any discomfort) appear to have started 5 or 6 days after the shot, on the same side of the body as the vaccine was administered.  She has not started her period yet, but has started light breast development and hormonal mood changes in a monthly cycle. Having heard some odd hormonal/inflammation reactions are occurring in women after the vaccines- I thought this might be one that could be seen in the emerging pubescent girls and so should report it.  I have a personal history of excess sex hormones (high baseline DHEA-S leading to high levels of Estrogen, Progesterone, and Testosterone), so as my daughter- she may also have more hormones than average.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Lost sense of taste
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Herpes zoster, Myalgia, Neuralgia, Pain in extremity
Clinical narrative: Pain on my arm for many weeks, little swelling, when arm healed,  my back began hurting and I developed a rash, was told it was nerve pain began 4/27/2021 Diagnosed with shingles on may 6th I still have some residual muscle pain as of 05/26/2021
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: Pain on my arm for many weeks, little swelling, when arm healed,  my back began hurting and I developed a rash, was told it was nerve pain began 4/27/2021 Diagnosed with shingles on may 6th I still have some residual muscle pain as of 05/26/2021
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain in extremity
Clinical narrative: Swollen, painful lymph nodes on both sides, worse on left side, left arm is extremely sore
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Bundle branch block left, Cardiac monitoring, Chest pain, Chills, Echocardiogram
Clinical narrative: Had expected fevers and chills day following vaccine. Started approximately 12 hours after shot and abated approximately 36 hours later. Of note, had a fever and chills when falling asleep night of 5/28  On 5/29 woke with specific chest pain localized to heart area. Waited approximately one hour to see if symptoms abated, then proceeded to ER to get checked out. EKG showed left branch block. Administration of Nitro and asprin alleviated chest pain. Was admitted to hospital for observation and testing to ensure heart functioning properly.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Pyrexia, Scan myocardial perfusion normal
Clinical narrative: Had expected fevers and chills day following vaccine. Started approximately 12 hours after shot and abated approximately 36 hours later. Of note, had a fever and chills when falling asleep night of 5/28  On 5/29 woke with specific chest pain localized to heart area. Waited approximately one hour to see if symptoms abated, then proceeded to ER to get checked out. EKG showed left branch block. Administration of Nitro and asprin alleviated chest pain. Was admitted to hospital for observation and testing to ensure heart functioning properly.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Myalgia, Oropharyngeal pain, Pain
Clinical narrative: Exposure to COVID-19 virus Muscle or body aches  Sore throat
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test
Clinical narrative: Exposure to COVID-19 virus Muscle or body aches  Sore throat
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site hypoaesthesia, Injection site pain, Injection site paraesthesia, Paraesthesia
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: pt complains of numbness/ tingling in arm of injection
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: Patient stood up within 5 minutes of recieving vaccine and fainted.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Patient stood up within 5 minutes of recieving vaccine and fainted.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: Systemic: Fainting / Unresponsive-Medium
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site urticaria, Rash
Clinical narrative: Patient showed copious rash and urticaria on the right arm (arm where the vaccine was injected)
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: AE: felt like patient was going to pass out Tx: no medication was given. water resolved the symptoms Outcome: Patient was discharged to POV/Home.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache
Clinical narrative: Headache, then a brain fog lasting months
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest discomfort, Chest pain, Electrocardiogram, Palpitations
Clinical narrative: Heart palpitations, chest pain, chest tightness. Started to go away within two weeks without medication. Visited urgent care, primary care and cardiologist
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Headache, Pain in extremity, Pyrexia
Clinical narrative: Fever, cold sweats, headache, sore arm.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Bilevel positive airway pressure, Chest discomfort, Dyspnoea, Grunting, Wheezing
Clinical narrative: 0905 tightening in chest, 0907 difficulty breathing-wheezing, grunting.  Epi .3 mg x3 IM.  Benadryl .25 po.  02 via nc at 3 LPM.  EMS on arrival gave Predisone IM and 02 via face mask Pt was taken to the ER for treatment.  Was started on BiPap overnight.  Was discharged home the next day.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: My period, which is normally very regular and predictable, has been completely thrown off since receiving the vaccine. It has never been more than 2 days late but since getting the vaccine, it has been one week late and 2 1/2 weeks late.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Pain, SARS-CoV-2 test
Clinical narrative: Exposure to COVID-19 virus Dx Generalized Body Aches
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: Pfizer-BioTech COVID-19 Vaccine EUA Shot 1: I had reported bleeding for 1 month. I went to doctor to rule out other reasons. Yes, highly a reaction to shot. Shot 2: THIS REPORT: now I haven't bled at all, plus other extreme symptoms. Like a rapid injection to go into menopause immediately! Side note: a family relative (early 30s) had a miscarriage soon after a shot.  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY ** Especially for UNDER 16; I'd even recommend STOP for under 40 In your emergency roll-out trials, you may have not seen an negative impact regarding fertility specifically (as those are the articles I keep coming across), HOWEVER THERE IS A NEGATIVE IMPACT on girls reproductive system!!  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY ** Please revisit your research and development. Remember shot was approved for emergency and NOT APPROVED. Please protect the girls. Remember, they are the ones that keep the human race going by having babies.  Please ** HALT VACCINES FOR GIRLS IMMEDIATELY **
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Immediate post-injection reaction, Nausea, Syncope
Clinical narrative: patient with immediate syncope with vaccination lasting less than 5 seconds.  patient recovered with no recurrence.   concomitant nausea without emesis and HA
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood albumin decreased, Blood chloride decreased, Blood creatinine normal, Blood culture
Clinical narrative: 71-year-old male with history of lymphoma on chemotherapy and heart transplant in 2011 on immune suppressants presenting with fever, fatigue, cough, shortness of breath x4 days.  Patient is afebrile upon arrival with otherwise normal vital signs.  He did desaturate to 88% while at rest and was placed on 2 L nasal cannula.  He has clear breath sounds bilaterally without any focal findings.  Work of breathing is not increased and very stable in my opinion.  He appears clinically euvolemic and denies history of heart failure.  No wheezing warranting treatment beta agonist.  Patient will require admission given his acute respiratory insufficiency, will need to discuss appropriate Campus placement with the Heart Transplant Service and anticipate he will require transfer to Grand Rapids.  Given his reported dyspnea, EKG ordered.  Will obtain routine screening labs, COVID-19 swab.  With his reported fever, although not objectively present during this visit, and current immunocompromised state, will treat via the emergency department sepsis protocol and collect blood cultures.  Fri May 21, 2021 1059 EKG with a normal sinus rhythm, rate of 88 beats per minute, no acute ischemic changes are noted.  Patient has a right bundle-branch block.  EKG is unchanged from that of January 21, 2021. BNP is 404, no chest pain to warrant cardiac biomarkers.   [SR] 1113 COVID-19 is detected.   [SR] 1125 CMP was sodium of 128, chloride 95, glucose 303, creatinine 0.87.  Magnesium is 1.9.  Phosphorus 2.1.  Urinalysis with trace blood, no urinary tract infection.  Urinalysis without urinary tract infection.   [SR] 1147 INR subtherapeutic at 1.2.   [SR] 1149 Received a critical result from lab, white blood cell count is 0.04, patient is by definition therefore neutropenic.  Platelets are 21 K without reported active bleeding.  Hemoglobin is 9.3.  Have a call out to Oncology to discuss need for IV cefepime given the reported fevers at home although etiologies presumably viral with COVID-19 test.  Further, I do not know if IV Decadron is appropriate given his profound neutropenia, especially having recently finished a high-dose course of 100 mg prednisone orally x5 days.   [SR] 1150 CXR: Airspace opacities are seen involving both the lungs, more prominent in the right lung, as described above. These are likely due to consolidation/pneumonia. Viral pneumonia can also have similar appearance. Correlate clinically.    [SR] 1218 Discussed case with Dr. from transplant team who agreed with admission to his service .  He did recommend that I broaden his antibiotic regimen to include both IV vancomycin and IV cefepime.  He recommended that I do provided dose of IV Decadron despite the neutropenia to treat his acute respiratory failure secondary to COVID-19.  Still awaiting call back from Oncology.   [SR] 1454 After multiple pages, I have not been connected to Oncology.  Patient was transported by EMS.  He will need a formal oncology consult upon arrival to admitting facility.   [SR]
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood lactic acid normal, Blood magnesium normal, Blood phosphorus decreased, Blood sodium decreased
Clinical narrative: 71-year-old male with history of lymphoma on chemotherapy and heart transplant in 2011 on immune suppressants presenting with fever, fatigue, cough, shortness of breath x4 days.  Patient is afebrile upon arrival with otherwise normal vital signs.  He did desaturate to 88% while at rest and was placed on 2 L nasal cannula.  He has clear breath sounds bilaterally without any focal findings.  Work of breathing is not increased and very stable in my opinion.  He appears clinically euvolemic and denies history of heart failure.  No wheezing warranting treatment beta agonist.  Patient will require admission given his acute respiratory insufficiency, will need to discuss appropriate Campus placement with the Heart Transplant Service and anticipate he will require transfer to Grand Rapids.  Given his reported dyspnea, EKG ordered.  Will obtain routine screening labs, COVID-19 swab.  With his reported fever, although not objectively present during this visit, and current immunocompromised state, will treat via the emergency department sepsis protocol and collect blood cultures.  Fri May 21, 2021 1059 EKG with a normal sinus rhythm, rate of 88 beats per minute, no acute ischemic changes are noted.  Patient has a right bundle-branch block.  EKG is unchanged from that of January 21, 2021. BNP is 404, no chest pain to warrant cardiac biomarkers.   [SR] 1113 COVID-19 is detected.   [SR] 1125 CMP was sodium of 128, chloride 95, glucose 303, creatinine 0.87.  Magnesium is 1.9.  Phosphorus 2.1.  Urinalysis with trace blood, no urinary tract infection.  Urinalysis without urinary tract infection.   [SR] 1147 INR subtherapeutic at 1.2.   [SR] 1149 Received a critical result from lab, white blood cell count is 0.04, patient is by definition therefore neutropenic.  Platelets are 21 K without reported active bleeding.  Hemoglobin is 9.3.  Have a call out to Oncology to discuss need for IV cefepime given the reported fevers at home although etiologies presumably viral with COVID-19 test.  Further, I do not know if IV Decadron is appropriate given his profound neutropenia, especially having recently finished a high-dose course of 100 mg prednisone orally x5 days.   [SR] 1150 CXR: Airspace opacities are seen involving both the lungs, more prominent in the right lung, as described above. These are likely due to consolidation/pneumonia. Viral pneumonia can also have similar appearance. Correlate clinically.    [SR] 1218 Discussed case with Dr. from transplant team who agreed with admission to his service .  He did recommend that I broaden his antibiotic regimen to include both IV vancomycin and IV cefepime.  He recommended that I do provided dose of IV Decadron despite the neutropenia to treat his acute respiratory failure secondary to COVID-19.  Still awaiting call back from Oncology.   [SR] 1454 After multiple pages, I have not been connected to Oncology.  Patient was transported by EMS.  He will need a formal oncology consult upon arrival to admitting facility.   [SR]